[Cliical aspects of cardiocinetic therapy with a new cardioactive glucoside: acetyldigoxin].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D002648:Child; D003327:Coronary Disease / Q000188:drug therapy*; D004077:Digoxin / Q000627:therapeutic use*; D005260:Female; D006330:Heart Defects, Congenital / Q000188:drug therapy*; D006331:Heart Diseases / Q000188:drug therapy*; D006349:Heart Valve Diseases / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D012214:Rheumatic Heart Disease / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
D004077:Digoxin
Aspetti clinici della terapia cardiocinetica con un nuovo glucoside cardioattivo: l'acetildigossina.